Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ePoster Display

1277P - Molecular features in young non-small cell lung cancer: A comparative analysis

Date

16 Sep 2021

Session

ePoster Display

Topics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Tongmei Zhang

Citation

Annals of Oncology (2021) 32 (suppl_5): S949-S1039. 10.1016/annonc/annonc729

Authors

T. Zhang1, M. Hu1, J. Tan2, N. Che3, D. Zhao3, Y. Gao1, B. Li1, L. Li4, Z. Liu4, X. Gao4

Author affiliations

  • 1 Department Of General Medicine, Beijing Chest Hospital, Capital Medical University & Beijing Tuberculosis and Tumor Research Institute, 101149 - Beijing/CN
  • 2 Department Of Celluar And Molecular Biology, Beijing Chest Hospital, Capital Medical University & Beijing Tuberculosis and Tumor Research Institute, 101149 - Beijing/CL
  • 3 Department Of Pathology, Beijing Chest Hospital, Capital Medical University & Beijing Tuberculosis and Tumor Research Institute, 101149 - Beijing/CN
  • 4 Genomics Institute, Geneplus-Beijing Institute, 102206 - Beijing/CN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1277P

Background

Young non-small cell lung cancer (NSCLC) patients under the age of 40 shows a low diagnosis rate and a low smoking rate with a more aggressive course and a poorer prognosis than the elderly. However, few studies have examined molecular alterations characteristics of this population. Here, we use next-generation sequencing (NGS) to compare the molecular variation spectrum differences between the young and the elderly.

Methods

A total of 73 young and 92 elderly NSCLC patients were enrolled. The FFPE (formalin fixed and paraffin embedded) surgical resection tissue samples were collected from 2014 to 2020 for NGS with a 1021-gene panel and the depth of 940×. The molecular variation landscapes of the youth and the elderly were compared. We also obtained 40 youth and 332 elderly NSCLC samples from the cBioportal database to verify our results.

Results

We found that the mutation rates of LRP1B、SMARCA4、STK11、FAT2、RBM10、FANCM genes in the elderly were significantly higher than in the youth. The mutation rates of EGFR 19DEL and 20INS in the young were higher than those in the elderly (16.4% vs 8.7%, 6.9% vs 1.1%), while the status of mutation rates of the L858R mutation was opposite (11.0% vs 22.8%). These results were consistent with data of public database. The frequency of EML4-ALK fusion was higher in the youth (11.0%) than in the elderly (2.2%). We also detected 9.6% BCL2L11 deletion (somatic) in the youth. Pyclone results show that EGFR mutations as the main clone in the young than in the elderly.

Conclusions

Compared with the elderly NSCLC, for the young NSCLC, the EGFR gene mutation was the main clone mutation with higher proportions of the 19DEL and 20INS, and a lower proportion of the L858R mutation. Besides, the ALK fusion variation was significantly higher in the young than that in the elderly. The intratumoral heterogeneity in the young was significantly lower than that in the elderly.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.